Medicare’s New $2,100 Drug Cap Quietly Rewrites the Math on Costly Prescriptions

A 68-year-old retiree on a $14,000-a-year specialty arthritis biologic used to brace for January. The old Part D structure pushed her through a deductible, an initial coverage phase, the so-called donut hole, and finally catastrophic coverage, where she still paid 5% coinsurance for the rest of the year. On a drug at that price, 5% kept bleeding for months. Starting this plan year, that bleeding stops at a hard number.

If your annual prescription bill never crosses four figures, this article does not change much for you. Roughly 1 in 10 Part D enrollees ever hits the cap. But if you, a spouse, or a parent is on a cancer pill, a biologic, a multiple sclerosis therapy, or any drug priced in the thousands per month, the math has been rewritten and the action items are different than they were a year ago.

The number that changed everything

For plan year 2026, Medicare Part D caps a beneficiary’s out-of-pocket spending on covered prescription drugs at $2,100. Once you hit that figure in copays, coinsurance, and deductible payments combined, you pay $0 for any additional covered Part D prescriptions for the rest of the calendar year. The cap replaced the donut hole and the 5% catastrophic coinsurance that used to run uncapped through December.

The cap started at $2,000 in 2025 under the Inflation Reduction Act and indexes each year to growth in average per-capita Part D drug spending. That indexing is why it ticked up by $100 for 2026. Expect it to keep drifting upward.

Three things the cap does not do, because misreading this is the most common mistake:

• It does not cap your monthly Part D premium. Premiums sit on top of the $2,100 and keep running every month.
• It does not cover drugs administered in a doctor’s office or infusion suite. Those bill under Part B, where you still owe 20% coinsurance unless you have a Medigap policy or Medicare Advantage out-of-pocket maximum that catches it.
• It does not cover drugs your plan’s formulary excludes. If your prescription is not on the plan’s covered list, none of the spending counts toward the $2,100.

What this is worth in real dollars

Take a Medicare enrollee on a $9,000-a-year oral cancer drug. Under the pre-2025 structure, that patient could easily owe $3,000 to $3,500 out of pocket across the year, with most of it landing in a single ugly month at the start. Under the 2026 rules, the same patient pays at most $2,100, and the bill stops for the rest of the year.

For someone on a $60,000-a-year specialty biologic, the savings are sharper. Pre-cap, 5% catastrophic coinsurance alone would have run $3,000 on the back half of that drug. Now the entire Part D obligation tops out at the same $2,100.

One January problem persists: many high-cost drug users still incur most of their out-of-pocket liability early in the year. That is where the Medicare Prescription Payment Plan comes in. It is a free, voluntary program that allows Part D enrollees to spread their out-of-pocket prescription costs across the calendar year instead of paying them all at the pharmacy counter when prescriptions are filled. The $2,100 ceiling stays the same; the program changes the timing of the payments, not the total amount owed.

What to do before open enrollment closes

Three concrete actions for anyone with high drug spending:

1. Re-shop your Part D plan every fall. The cap is identical across plans, but premiums, deductibles, formularies, and preferred-pharmacy networks are not. Insurers have responded to the cap by moving more drugs to higher tiers and tightening formularies, so the plan that covered your prescription cheapest last year may not this year. Auto-renewal is the trap.
2. Consider the Medicare Prescription Payment Plan if your drug costs are concentrated early in the year or if a large pharmacy bill would strain your monthly budget. Contact your Part D plan or enroll through your plan’s portal. It does not reduce your total cost, but it can spread those costs over the calendar year.
3. Confirm your drug is Part D, not Part B. Infused and injected drugs given in a clinic typically fall under Part B, where the $2,100 cap does not apply. If that is your situation, a Medigap Plan G is the supplement that actually caps your exposure on the standard Part B premium of $202.90 a month plus 20% coinsurance.

Source note: 2026 figures from the CMS Draft CY 2026 Part D Redesign Program Instructions and the CMS 2026 Medicare Parts A & B Premiums and Deductibles fact sheet.